Related Experiment Video
Updated: Dec 11, 2025
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G Laing1, Anna Lorenc1, Irene Del Molino Del Barrio1,2
1Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Insights
Researchers identified a distinct immune signature in COVID-19 patients, revealing key changes in immune cells and proteins. This signature may help predict disease severity and guide treatment strategies for SARS-CoV-2 infection.
Area of Science:
- Immunology
- Virology
- Clinical Medicine
Background:
- COVID-19, caused by SARS-CoV-2, presents a significant global health challenge.
- Effective management and understanding of COVID-19 pathogenesis are crucial for reducing its impact.
Purpose of the Study:
- To identify a core peripheral blood immune signature in hospital-treated COVID-19 patients.
- To explore the relationship between immune traits and disease severity, progression, and pathogenesis.
Main Methods:
- Analysis of peripheral blood immune cell composition and phenotypes.
- Quantification of cytokine/chemokine levels and SARS-CoV-2-specific antibodies.
- Correlation of immune signature components with clinical data.
Main Results:
- A core immune signature was identified, including altered B cell, myelomonocytic, and T cell populations.
- Depletion of basophils and plasmacytoid dendritic cells correlated with disease severity.
- Specific cytokine profiles (IP-10, IL-10, IL-6) predicted clinical progression.
Conclusions:
- The identified immune signature offers insights into COVID-19 pathogenesis.
- Individual and collective traits may guide treatment decisions and patient stratification.
- Further validation in diverse COVID-19 cohorts is warranted.
Abstract:
Improved understanding and management of COVID-19, a potentially life-threatening disease, could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end, we have identified a core peripheral blood immune signature across 63 hospital-treated patients with COVID-19 who were otherwise highly heterogeneous. The signature includes discrete changes in B and myelomonocytic cell composition, profoundly altered T cell phenotypes, selective cytokine/chemokine upregulation and SARS-CoV-2-specific antibodies. Some signature traits identify links with other settings of immunoprotection and immunopathology; others, including basophil and plasmacytoid dendritic cell depletion, correlate strongly with disease severity; while a third set of traits, including a triad of IP-10, interleukin-10 and interleukin-6, anticipate subsequent clinical progression. Hence, contingent upon independent validation in other COVID-19 cohorts, individual traits within this signature may collectively and individually guide treatment options; offer insights into COVID-19 pathogenesis; and aid early, risk-based patient stratification that is particularly beneficial in phasic diseases such as COVID-19.
Related Concept Videos
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...